3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Terminated
1
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Leukemia, Myeloid, Acute
18
Recurrence
6
Precursor Cell Lymphoblastic Leukemia-Lymphoma
6
Leukemia, Monocytic, Acute
6
Prostatic Neoplasms
5
Leukemia, Myelomonocytic, Acute
5
Leukemia, Megakaryoblastic, Acute
5
Leukemia, Erythroblastic, Acute
5
Leukemia
5
Congenital Abnormalities
4
Lymphoma, Follicular
3
Myelodysplastic Syndromes
2
Lymphoma, Non-Hodgkin
2
Lymphoma, Mantle-Cell
2
Lymphoma
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
1
Pain
1
Ovarian Neoplasms
1
Neoplasms, Plasma Cell
1
Neoplasms
1
Myeloid Malignancies
1
Multiple Myeloma
1
Lymphoma, Large B-Cell, Diffuse
1
Leukemia, T-Cell
1
Leukemia, Myelomonocytic, Juvenile
1
Leukemia, Eosinophilic, Acute
1
Leukemia, Biphenotypic, Acute
1
Leukemia, Basophilic, Acute
1
Interventions
Morphine
7
Fentanyl
5
Radiotherapy
4
Methadone
4
Zoledronic Acid
3
Tapentadol
2
Ropivacaine
2
Pregabalin
2
Prednisone
2
Ketamine
2
Ibandronic Acid
2
Hydromorphone
2
Glutamine
2
Cryotherapy
2
Cryosurgery
2
Bupivacaine
2
Acupuncture Therapy
2
Acetaminophen
2
pegfilgrastim
1
oxycodone naloxone combination
1
naloxegol
1
ixabepilone
1
incobotulinumtoxinA
1
imisopasem manganese
1
cyclobenzaprine
1
cabozantinib
1
acetaminophen, aspirin, caffeine drug combination
1
Zolpidem
1
Surveys and Questionnaires
1
Sugars
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Pain
×
Mitoxantrone
×
Clear all
NCT01522443
2018-05-23
COMET-2
Exelixis
Phase 3
Terminated
119 enrolled
21 charts